A comprehensive LC-MS-based quantitative analysis of fentanyl-like drugs in plasma and urine

Journal of Separation Science

Volumn 33, Issue 17-18, 2010, Pages 2654-2662

  Cooreman, Sarah ^a   Deprez, Christa ^a   Martens, Frank ^a   Van Bocxlaer, Jan ^b   Croes, Kathleen ^a  

^a AZ GROENINGE   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Fentanyl; Fentanyl like drugs; LC MS MS; Quantification; Toxicology

Indexed keywords

ANALYTES; ANALYTICAL METHOD; ANALYTICAL PROCEDURE; CONCENTRATION RANGES; CORRELATION COEFFICIENT; ELECTROSPRAYS; FENTANYLS; INTERNAL STANDARDS; IONISATION; LC-MS/MS; LIQUID-LIQUID EXTRACTION; MATRIX EFFECTS; QUANTIFICATION; QUANTITATIVE ANALYSIS; REMIFENTANIL; TOXICOLOGY;

BODY FLUIDS; ELECTROSPRAY IONIZATION; IONIZATION; LIQUIDS; SOLVENT EXTRACTION; STANDARDS;

ANESTHETICS;

ALFENTANIL; FENTANYL; FENTANYL D 5; MEFENTANYL; NORFENTANYL; NORFENTANYL D 5; REMIFENTANIL; SUFENTANIL; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BLOOD EXAMINATION; CALIBRATION; DRUG DETERMINATION; DRUG STABILITY; ELECTROSPRAY; LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; URINALYSIS;

ANALGESICS, OPIOID; ANIMALS; CATTLE; CHROMATOGRAPHY, LIQUID; FENTANYL; LIMIT OF DETECTION; MASS SPECTROMETRY; MOLECULAR STRUCTURE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77956909308     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.201000330     Document Type: Article

References (26)

1. Muijsers, R. B., Wagstaff, A. J., Drugs 2001, 61, 2289-2307.
2. Beers, R., Camporesi, E., CNS Drugs 2004, 18, 1085-1104.
3. Ropero-Miller, J. D., Clin. Forensic Toxicol. News 2006, 1-6.
4. Goldfrank, L. R., Flomenbaum, N. E., Lewin, N., Howland, M. A., Hofman, R., Nelson, L., Goldfrank's Toxicologic Emergencies, McGraw-Hill, New York 2002, pp. 901-923.
5. Baselt, R. C., Disposition of Toxic Drugs and Chemicals in Man, Biomedical Publications, Foster City, CA 2002.
6. Coopman, V., Cordonnier, J., Pien, K., Van Varenbergh, D., Forensic Sci. Int. 2007, 169, 223-227.
7. Peer, C. J., Shakleya, D. M., Younis, I. R., Kraner, J. C., Callery, P. S., J. Anal. Toxicol. 2007, 31, 515-521.
8. Isenschmid, D., Clin. Forensic Toxicol. News 2007, 1-7.
9. Van Nimmen, N. F. J., Poels, K. L. C., Veulemans, H. A. F., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 804, 375-387.
10. Scott, L. J., Perry, C. M., Drugs 2005, 65, 1793-1823.
11. Michiels, M., Hendriks, R., Heykants, J., Eur. J. Clin. Pharmacol. 1977, 12, 153-158.
12. Michiels, M., Hendriks, R., Heykants, J., J. Pharm. Pharmacol. 1983, 35, 86-93.
13. Gillespie, T. J., Gandolfi, A. J., Maiorino, R. M., Vaughan, R. W., J. Anal. Toxicol. 1981, 5, 133-137.
14. Gillespie, T. J., Gandolfi, A. J., Davis, T. P., Morano, R. A., J. Anal. Toxicol. 1982, 6, 139-142.
15. Van Rooy, H. H., Vermeulen, N. P. E., Bovill, J. G., J. Chromatogr. 1981, 223, 85-93.
16. Paradis, C., Dufresne, C., Bolon, M., Boulieu, R., Ther. Drug Monit. 2002, 24, 768-774.
17. Kumar, K., Morgan, D. J., Crankshaw, D. P., J. Chromatogr. 1987, 419, 464-468.
18. Portier, E. J. G., de Blok, K., Butter, J. J., van Boxtel, C. J., J. Chromatogr. B Biomed. Sci. Appl. 1999, 723, 313-318.
19. Palleschi, L., Lucentini, L., Ferretti, E., Anastasi, F., Amoroso, M., Draisci, G., J. Pharm. Biomed. Anal. 2003, 32, 329-336.
20. Bagheri, H., Es-haghi, A., Khalilian, F., Rouini, M. R., J. Pharm. Biomed. Anal. 2007, 43, 1763-1768.
21. Huynh, N. H., Tyrefors, N., Ekman, L., Johansson, M., J. Pharm. Biomed. Anal. 2005, 37, 1095-1100.
22. Thevis, M., Geyer, H., Bahr, D., Schänzer, W., Eur. J. Mass Spectrom. 2005, 11, 419-427.
23. FDA-CDER and CVM, Guidance for Industry - Bioanalytical Method Validation, May 2001.
24. Matuszewski, B. K., Constanzer, M. L., Chavez-Eng, C. M., Anal. Chem. 2003, 75, 3019-3030.
25. Dufresne, C., Favetta, P., Paradis, C., Boulieu, R., Ther. Drug Monitor. 2001, 23, 550-552.
26. Schmidt, R., Bremerich, D. H., Geisslinger, G., J. Chromatogr. B 2006, 836, 98-107.